AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34948533 — intervention group
Group type: EXPERIMENTAL
Intervention: Giacometti artwork nudge
Number of subjects: 904
Study 34948533 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin body shape nudge
Number of subjects: 904
Study 34948533 — intervention group
Group type: EXPERIMENTAL
Intervention: Thick body shape nudge
Number of subjects: 904
Study 34948533 — intervention group
Group type: EXPERIMENTAL
Intervention: Giacometti nudge
Number of subjects: 904
Study 32571720 — intervention group
Group type: EXPERIMENTAL
Intervention: FMP2.1/AS02A malaria vaccine
Number of subjects: 0
Study 32571720 — intervention group
Group type: COMPARATOR
Intervention: Control (rabies vaccine)
Number of subjects: 0
Study 36257912 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost eye drops
Number of subjects: 108
Study 36257912 — intervention group
Group type: EXPERIMENTAL
Intervention: Minoxidil 5% solution
Number of subjects: 108
Study 36257912 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost eye drops and minoxidil 5% solution
Number of subjects: 108
Study 36257912 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone and minoxidil 5% solution
Number of subjects: 108
Study 36257912 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone solution and latanoprost eye drops
Number of subjects: 108
Study 36257912 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone solution
Number of subjects: 108
Study 32380132 — intervention group
Group type: EXPERIMENTAL
Intervention: Single impression (stock tray and irreversible hydrocolloid)
Number of subjects: 52
Study 32380132 — intervention group
Group type: COMPARATOR
Intervention: Two‐step impression (custom tray, border molding with compound, and polyether)
Number of subjects: 52
Study 32380132 — intervention group
Group type: EXPERIMENTAL
Intervention: Single impression
Number of subjects: 52
Study 32380132 — intervention group
Group type: COMPARATOR
Intervention: Two‐step impression
Number of subjects: 52
Study 37811576 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional rotary device
Number of subjects: 80
Study 37811576 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic unit
Number of subjects: 80
Study 37811576 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 80
Study 37811576 — intervention group
Group type: COMPARATOR
Intervention: Laser and piezo groups
Number of subjects: 80
Study 37811576 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteotome used
Number of subjects: 80
Study 37811576 — intervention group
Group type: EXPERIMENTAL
Intervention: Trismus
Number of subjects: 80
Study 34429313 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeon-led care (usual care)
Number of subjects: 353
Study 34429313 — intervention group
Group type: EXPERIMENTAL
Intervention: GP-led care
Number of subjects: 353
Study 34429313 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth application (Oncokompas)
Number of subjects: 353
Study 34429313 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 353
Study 32993752 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture at specific acupuncture points with penetrating needling, 5 sessions over 3 menstrual cycles
Number of subjects: 300
Study 32993752 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture with non-penetrating needling at non-acupuncture points, 5 sessions over 3 menstrual cycles
Number of subjects: 300
Study 32993752 — intervention group
Group type: COMPARATOR
Intervention: Usual care with health education and manual acupuncture after 7 menstrual cycles
Number of subjects: 300
Study 32993752 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture
Number of subjects: 300
Study 35195519 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid test units
Number of subjects: 722
Study 35195519 — intervention group
Group type: COMPARATOR
Intervention: Usual-care units
Number of subjects: 722
Study 35195519 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid test
Number of subjects: 722
Study 35195519 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 722
Study 34406327 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine-mediated G-protein receptor kinase 2 inhibition
Number of subjects: 18
Study 34406327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 34702654 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine (200 mg/day up-titrated to 600 mg/day over 18 days)
Number of subjects: 25
Study 34702654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 34702654 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 25
Study 33367578 — intervention group
Group type: EXPERIMENTAL
Intervention: CRK contamination from handwashing sinks
Number of subjects: 158
Study 33367578 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical isolates of CRKP
Number of subjects: 158
Study 33367578 — intervention group
Group type: EXPERIMENTAL
Intervention: ST789 clone
Number of subjects: 158
Study 33367578 — intervention group
Group type: EXPERIMENTAL
Intervention: ST11_KL47 sink isolates
Number of subjects: 158
Study 33367578 — intervention group
Group type: EXPERIMENTAL
Intervention: ST11_KL64 isolates
Number of subjects: 158
Study 35422046 — intervention group
Group type: EXPERIMENTAL
Intervention: RG formula
Number of subjects: 60
Study 34147585 — intervention group
Group type: EXPERIMENTAL
Intervention: Active interpretation bias training (IBT)
Number of subjects: 44
Study 34147585 — intervention group
Group type: COMPARATOR
Intervention: Sham computerized IBT training
Number of subjects: 44
Study 32008920 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck dissection (ND) performed on 46% of patients
Number of subjects: 322
Study 32008920 — intervention group
Group type: COMPARATOR
Intervention: No neck dissection (ND)
Number of subjects: 322
Study 35854347 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week hybrid mindfulness-based intervention (MBI) consisting of 6 weekly 90-min group-based sessions delivered through face-to-face and online approach.
Number of subjects: 0
Study 35854347 — intervention group
Group type: COMPARATOR
Intervention: Brief education on dementia care (Control group).
Number of subjects: 0
Study 34476575 — intervention group
Group type: EXPERIMENTAL
Intervention: HEP (liver metastases)
Number of subjects: 18
Study 34476575 — intervention group
Group type: COMPARATOR
Intervention: M0 (no distant metastases)
Number of subjects: 18
Study 34476575 — intervention group
Group type: COMPARATOR
Intervention: PER (peritoneal carcinomatosis)
Number of subjects: 18
Study 35297224 — intervention group
Group type: EXPERIMENTAL
Intervention: POI sleep intervention
Number of subjects: 683
Study 33138867 — intervention group
Group type: EXPERIMENTAL
Intervention: C-IVIG 0.15g/Kg with standard hospital care
Number of subjects: 50
Study 33138867 — intervention group
Group type: EXPERIMENTAL
Intervention: C-IVIG 0.2g/Kg with standard hospital care
Number of subjects: 50
Study 33138867 — intervention group
Group type: EXPERIMENTAL
Intervention: C-IVIG 0.25g/Kg with standard hospital care
Number of subjects: 50
Study 33138867 — intervention group
Group type: EXPERIMENTAL
Intervention: C-IVIG 0.3g/Kg with standard hospital care
Number of subjects: 50
Study 33138867 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital care only
Number of subjects: 50
Study 36063140 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency financial assistance
Number of subjects: 0
Study 36063140 — intervention group
Group type: COMPARATOR
Intervention: Non-receipt of emergency assistance (treatment group who did not receive assistance)
Number of subjects: 0
Study 36063140 — intervention group
Group type: COMPARATOR
Intervention: Experimental control group (randomly assigned)
Number of subjects: 0
Study 33715085 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 80
Study 33715085 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 80
Study 32061968 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-hour educational workshop about a patient-centered approach to opioid therapy
Number of subjects: 293
Study 32061968 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational workshop plus a collaborative care intervention delivered by a nurse care manager (NCM)
Number of subjects: 293
Study 32061968 — intervention group
Group type: COMPARATOR
Intervention: Control group (educational workshop only)
Number of subjects: 293
Study 32290858 — intervention group
Group type: EXPERIMENTAL
Intervention: Infection by Chlamydia pneumoniae
Number of subjects: 0
Study 32290858 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower immunities (elderly individuals)
Number of subjects: 0
Study 32290858 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher immunities (younger individuals)
Number of subjects: 0
Study 35652491 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 123
Study 33287772 — intervention group
Group type: EXPERIMENTAL
Intervention: MIP
Number of subjects: 1350
Study 33287772 — intervention group
Group type: EXPERIMENTAL
Intervention: MIP+SMS
Number of subjects: 1350
Study 33287772 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 1350
Study 35994868 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program attended once weekly for 4 weeks
Number of subjects: 40
Study 35994868 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program
Number of subjects: 40
Study 35994868 — intervention group
Group type: COMPARATOR
Intervention: Usual information provided to control group
Number of subjects: 40
Study 33801705 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam 240 mg (Group N240)
Number of subjects: 78
Study 33801705 — intervention group
Group type: COMPARATOR
Intervention: Nefopam 120 mg with fentanyl 600 μg (Group NF)
Number of subjects: 78
Study 35939810 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ensovibep, 600 mg
Number of subjects: 485
Study 32899946 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-min walking test with inertial units measuring lower limb kinematics
Number of subjects: 9
Study 34238397 — intervention group
Group type: EXPERIMENTAL
Intervention: High adiposity category children
Number of subjects: 20
Study 34238397 — intervention group
Group type: COMPARATOR
Intervention: Low and average adiposity category children
Number of subjects: 20
Study 34688253 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior clinical care for migraine (n=94)
Number of subjects: 117
Study 34688253 — intervention group
Group type: EXPERIMENTAL
Intervention: No prior clinical care for migraine (n=23)
Number of subjects: 117
Study 34688253 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (n=36)
Number of subjects: 117
Study 34688253 — intervention group
Group type: EXPERIMENTAL
Intervention: Both patient groups (with and without prior care)
Number of subjects: 117
Study 32456250 — intervention group
Group type: EXPERIMENTAL
Intervention: True air purifiers
Number of subjects: 32
Study 32456250 — intervention group
Group type: COMPARATOR
Intervention: Sham air purifiers
Number of subjects: 32
Study 35585374 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofersen (investigational antisense oligonucleotide designed to reduce synthesis of SOD1 protein)
Number of subjects: 0
Study 35585374 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 32554648 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipatory Care Planning (ACP) through home visits and personalized support plans
Number of subjects: 64
Study 32554648 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 64
Study 34483094 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable vascular scaffold (BVS)
Number of subjects: 1845
Study 34483094 — intervention group
Group type: COMPARATOR
Intervention: XIENCE everolimus-eluting stent (EES)
Number of subjects: 1845
Study 34483094 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable vascular scaffold (BVS) on DAPT
Number of subjects: 1845
Study 34675309 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical capsaicin application
Number of subjects: 22
Study 34675309 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 22
Study 34675309 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 33114186 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (PRO)
Number of subjects: 54
Study 33114186 — intervention group
Group type: COMPARATOR
Intervention: Isoenergetic carbohydrate (CHO)
Number of subjects: 54
Study 33114186 — intervention group
Group type: COMPARATOR
Intervention: Water/placebo (H2O)
Number of subjects: 54
Study 36201973 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound for confirming ETT depth (high placement)
Number of subjects: 3
Study 36201973 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound for confirming ETT depth (middle placement)
Number of subjects: 3
Study 36201973 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound for confirming ETT depth (deep placement)
Number of subjects: 3
Study 34495336 — intervention group
Group type: COMPARATOR
Intervention: 400 IU of oral vitamin D3 supplementation daily
Number of subjects: 801
Study 34495336 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 IU of oral vitamin D3 supplementation daily
Number of subjects: 801
Study 35881629 — intervention group
Group type: EXPERIMENTAL
Intervention: Defense of mental impairment
Number of subjects: 1601
Study 35881629 — intervention group
Group type: COMPARATOR
Intervention: Guilty plea
Number of subjects: 1601
Study 34376917 — intervention group
Group type: EXPERIMENTAL
Intervention: Test food containing anthocyanin, astaxanthin, and lutein, taken as 2 capsules once daily for 6 weeks
Number of subjects: 44
Study 34376917 — intervention group
Group type: COMPARATOR
Intervention: Placebo, taken as 2 capsules once daily for 6 weeks
Number of subjects: 44
Study 36003050 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus rhamnosus GG (LGG) 1 x 10^10 CFU/daily for 12 weeks
Number of subjects: 100
Study 36003050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 36003050 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus rhamnosus GG (LGG)
Number of subjects: 100
Study 32554219 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 levels
Number of subjects: 289
Study 32554219 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 tertiles
Number of subjects: 289
Study 35748547 — intervention group
Group type: EXPERIMENTAL
Intervention: Echium amoenum-Melissa officinalis syrup and fluvoxamine
Number of subjects: 40
Study 35748547 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup and fluvoxamine
Number of subjects: 40
Study 32486864 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Partial Nephrectomy (LPN)
Number of subjects: 108
Study 32486864 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Partial Nephrectomy (RAPN)
Number of subjects: 108
Study 33938966 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy (IORT) with a single dose of 20 Gy
Number of subjects: 214
Study 33938966 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-breast irradiation (WBI)
Number of subjects: 214
Study 33938966 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 214
Study 33938966 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsilateral breast tumor recurrence (IBTR)
Number of subjects: 214
Study 33938966 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral breast event (CBE)
Number of subjects: 214
Study 33938966 — intervention group
Group type: EXPERIMENTAL
Intervention: Distant metastasis-free survival (DMFS)
Number of subjects: 214
Study 32861306 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative shared care delivered by trained TFH and primary health-care workers (PHCW)
Number of subjects: 307
Study 32861306 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative shared care delivered by trained TFH and PHCW
Number of subjects: 307
Study 32861306 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care as usual (control)
Number of subjects: 307
Study 36229604 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation teaching unit based on mental contrasting with implementation intentions; details on dosage and duration not specified.
Number of subjects: 0
Study 36229604 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified; details on intervention not available.
Number of subjects: 0
Study 33201025 — intervention group
Group type: EXPERIMENTAL
Intervention: 2RDA (1.6 g/kg body weight)
Number of subjects: 26
Study 33201025 — intervention group
Group type: COMPARATOR
Intervention: RDA (0.8 g/kg body weight)
Number of subjects: 26
Study 34053250 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task (DT) walking intervention
Number of subjects: 45
Study 34053250 — intervention group
Group type: COMPARATOR
Intervention: Single-task (ST) walking intervention
Number of subjects: 45
Study 34053250 — intervention group
Group type: EXPERIMENTAL
Intervention: fNIRS measurement during DT walking
Number of subjects: 45
Study 34053250 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI analysis
Number of subjects: 45
Study 35428615 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 248
Study 35428615 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 248
Study 33141790 — intervention group
Group type: EXPERIMENTAL
Intervention: CSM-based intervention consisting of five weekly group-based education sessions
Number of subjects: 455
Study 33141790 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving five weekly educational booklets
Number of subjects: 455
Study 32843718 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based lifestyle intervention program with face-to-face educational sessions
Number of subjects: 9204
Study 32843718 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based lifestyle intervention program
Number of subjects: 9204
Study 32843718 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 9204
Study 34971596 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded Exposure Therapy (GET)
Number of subjects: 73
Study 34971596 — intervention group
Group type: COMPARATOR
Intervention: Operant Condition‐Based Pacing Strategies plus Mindfulness Training (Pacing+)
Number of subjects: 73
Study 32411324 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Glutamine (Gln) supplementation
Number of subjects: 83
Study 32411324 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Glutamine (Gln) supplementation in CET group
Number of subjects: 83
Study 32411324 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Glutamine (Gln) supplementation in NP group
Number of subjects: 83
Study 32411324 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) in NP group
Number of subjects: 83
Study 32411324 — intervention group
Group type: COMPARATOR
Intervention: Combined-Exercise Training (CET)
Number of subjects: 83
Study 32411324 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 83
Study 33051793 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure occlusion group (LPO)
Number of subjects: 33
Study 33051793 — intervention group
Group type: COMPARATOR
Intervention: High-pressure occlusion group (HPO)
Number of subjects: 33
Study 33245000 — intervention group
Group type: EXPERIMENTAL
Intervention: FindMyApps intervention (n=28)
Number of subjects: 59
Study 33245000 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=31)
Number of subjects: 59
Study 34000958 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT) capsules for 12 days
Number of subjects: 52
Study 34000958 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for 12 days
Number of subjects: 52
Study 35907867 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-month physical activity intervention with in-person classes, social support, and environmental changes led by community health workers (promotoras)
Number of subjects: 436
Study 35907867 — intervention group
Group type: COMPARATOR
Intervention: Attention-control condition
Number of subjects: 436
Study 33743647 — intervention group
Group type: EXPERIMENTAL
Intervention: Sa‐Chan Japan (animation)
Number of subjects: 1002
Study 33743647 — intervention group
Group type: COMPARATOR
Intervention: Mari Info Japan (control animation)
Number of subjects: 1002
Study 32919779 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin use (≥once/week)
Number of subjects: 41633
Study 32919779 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily use of aspirin
Number of subjects: 41633
Study 32919779 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 41633
Study 32919779 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily use of low-dose aspirin
Number of subjects: 41633
Study 35476631 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg moxidectin
Number of subjects: 0
Study 35476631 — intervention group
Group type: COMPARATOR
Intervention: 150 μg/kg ivermectin
Number of subjects: 0
Study 34418361 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide
Number of subjects: 0
Study 34418361 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33988332 — intervention group
Group type: EXPERIMENTAL
Intervention: tSFE
Number of subjects: 56
Study 33988332 — intervention group
Group type: COMPARATOR
Intervention: lSFE
Number of subjects: 56
Study 32175586 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (AZ) 250 mg twice daily for 3.5 days
Number of subjects: 10
Study 32175586 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 33325645 — intervention group
Group type: EXPERIMENTAL
Intervention: COMB (canagliflozin plus teneligliptin)
Number of subjects: 0
Study 33325645 — intervention group
Group type: COMPARATOR
Intervention: SWITCH (switching from teneligliptin to canagliflozin)
Number of subjects: 0
Study 32720823 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 1 mg orally 12 to 24 hours before surgery followed by 0.5 mg daily until discharge
Number of subjects: 152
Study 32720823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 35300888 — intervention group
Group type: EXPERIMENTAL
Intervention: Thulium fibre laser (TFL)
Number of subjects: 120